Thrombotic thrombocytopenic purpura and its diagnosis

被引:68
作者
Veyradier, A
Meyer, D
机构
[1] Hop Bicetre, INSERM, U143, F-94276 Le Kremlin Bicetre, France
[2] Hop Antoine Beclere, Serv Hematol Biol, Clamart, France
关键词
D O I
10.1111/j.1538-7836.2005.01350.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2420 / 2427
页数:8
相关论文
共 52 条
[1]   THROMBOTIC THROMBOCYTOPENIC PURPURA - REPORT OF 16 CASES AND REVIEW OF LITERATURE [J].
AMOROSI, EL ;
ULTMANN, JE .
MEDICINE, 1966, 45 (02) :139-+
[2]   Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome [J].
Amoura, Z ;
Costedoat-Chalumeau, N ;
Veyradier, AS ;
Wolf, M ;
Ghillani-Dalbin, P ;
Cacoub, P ;
Meyer, D ;
Piette, JC .
ARTHRITIS AND RHEUMATISM, 2004, 50 (10) :3260-3264
[3]   IMMUNOHISTOCHEMISTRY OF VASCULAR LESION IN THROMBOTIC THROMBOCYTOPENIC PURPURA, WITH SPECIAL REFERENCE TO FACTOR-VIII RELATED ANTIGEN [J].
ASADA, Y ;
SUMIYOSHI, A ;
HAYASHI, T ;
SUZUMIYA, J ;
KAKETANI, K .
THROMBOSIS RESEARCH, 1985, 38 (05) :469-479
[4]   Catastrophic antiphospholipid syndrome -: Clinical and laboratory features of 50 patients [J].
Asherson, RA ;
Cervera, R ;
Piette, JC ;
Font, J ;
Lie, JT ;
Burcoglu, A ;
Lim, K ;
Muñoz-Rodríguez, FJ ;
Levy, RA ;
Boué, F ;
Rossert, J ;
Ingelmo, M .
MEDICINE, 1998, 77 (03) :195-207
[5]   Successful treatment of a young infant who developed high-titer inhibitors against VWF-cleaving protease (ADAMTS-13): Important discrimination from Upshaw-Schulman syndrome [J].
Ashida, A ;
Nakamura, H ;
Yoden, A ;
Tamai, H ;
Ishizashi, H ;
Yagi, H ;
Matsumoto, M ;
Fujimura, Y .
AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (04) :318-322
[6]   Thrombotic thrombocytopenic purpura associated with clopidogrel. [J].
Bennett, CL ;
Connors, JM ;
Carwile, JM ;
Moake, JL ;
Bell, WR ;
Tarantolo, SR ;
McCarthy, LJ ;
Sarode, R ;
Hatfield, AJ ;
Feldman, MD ;
Davidson, CJ ;
Tsai, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (24) :1773-1777
[7]   Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders:: a severely deficient activity is specific for thrombotic thrombocytopenic purpura [J].
Bianchi, V ;
Robles, R ;
Alberio, L ;
Furlan, M ;
Lämmle, B .
BLOOD, 2002, 100 (02) :710-713
[8]   Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement [J].
Coppo, P ;
Bengoufa, D ;
Veyradier, A ;
Wolf, M ;
Bussel, A ;
Millot, GA ;
Malot, S ;
Heshmati, F ;
Mira, JP ;
Boulanger, E ;
Galicier, L ;
Durey-Dragon, MA ;
Frémeaux-Bacchi, V ;
Ramakers, M ;
Pruna, A ;
Bordessoule, D ;
Gouilleux, V ;
Scrobohaci, ML ;
Vernant, JP ;
Moreau, D ;
Azoulay, E ;
Schlemmer, B ;
Guillevin, L ;
Lassoued, K .
MEDICINE, 2004, 83 (04) :233-244
[9]   Plasma therapy in thrombotic thrombocytopenic purpura:: Review of the literature and the bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency [J].
Fontana, S ;
Hovinga, JAK ;
Studt, JD ;
Alberio, L ;
Lämmle, B ;
Taleghani, BM .
SEMINARS IN HEMATOLOGY, 2004, 41 (01) :48-59
[10]   Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [J].
Furlan, M ;
Robles, R ;
Galbusera, M ;
Remuzzi, G ;
Kyrle, PA ;
Brenner, B ;
Krause, M ;
Scharrer, I ;
Aumann, V ;
Mittler, U ;
Solenthaler, M ;
Lämmle, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1578-1584